Abstract:Chronic wounds occur as a consequence of a prolonged inflammatory phase during the healing process, which precludes skin regeneration. Typical treatment for chronic wounds includes application of autografts, allografts collected from cadaver, and topical delivery of antioxidant, anti-inflammatory, and antibacterial agents. Nevertheless, the mentioned therapies are not sufficient for extensive or deep wounds. Moreover, application of allogeneic skin grafts carries high risk of rejection and treatment failure. Advanced therapies for chronic wounds involve application of bioengineered artificial skin substitutes to overcome graft rejection as well as topical delivery of mesenchymal stem cells to reduce inflammation and accelerate the healing process. This review focuses on the concept of skin tissue engineering, which is a modern approach to chronic wound treatment. The aim of the article is to summarize common therapies for chronic wounds and recent achievements in the development of bioengineered artificial skin constructs, including analysis of biomaterials and cells widely used for skin graft production. This review also presents attempts to reconstruct nerves, pigmentation, and skin appendages (hair follicles, sweat glands) using artificial skin grafts as well as recent trends in the engineering of biomaterials, aiming to produce nanocomposite skin substitutes (nanofilled polymer composites) with controlled antibacterial activity. Finally, the article describes the composition, advantages, and limitations of both newly developed and commercially available bioengineered skin substitutes.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the challenges in chronic wound treatment, especially how to reconstruct functional skin tissue in vitro through tissue - engineering methods. Chronic wounds cannot regenerate skin normally due to the prolonged inflammatory phase during the healing process. Traditional treatment methods such as autologous transplantation, allogeneic transplantation, and local application of antioxidants, anti - inflammatory agents, and antibacterial agents have limited therapeutic effects on large - area or deep - wound treatment, and allogeneic skin transplantation has a relatively high rejection risk. Therefore, this review focuses on skin tissue - engineering technology, which is a modern method for chronic wound treatment, aiming to overcome the limitations of traditional therapies and promote more effective skin regeneration and repair. The paper mentions that in order to improve the treatment effect of chronic wounds, researchers are exploring the use of bioengineered artificial skin substitutes. These substitutes can reduce transplantation rejection reactions, and at the same time, relieve inflammation and accelerate the healing process by locally delivering mesenchymal stem cells. In addition, the article also discusses the possibility of using artificial skin transplantation to attempt to reconstruct nerves, pigmentation, and skin appendages (such as hair follicles and sweat glands), as well as the latest trends in the field of biomaterial engineering at present, such as the development of nano - composite skin substitutes (nano - filled polymer composites) with controllable antibacterial activity. Finally, the article describes the composition, advantages, and limitations of newly developed and commercially available bioengineered skin substitutes.

A Concise Review on Tissue Engineered Artificial Skin Grafts for Chronic Wound Treatment: Can We Reconstruct Functional Skin Tissue In Vitro?